Merit Medical Reports Third Quarter 2025 Results and Updates Full-Year Guidance

Merit Medical Reports Third Quarter 2025 Results and Updates Full-Year Guidance GlobeNewswire October 30, 2025 Highlights† Reported revenue of $384.2 million, up 13.0% Constant currency revenue* and constant currency revenue, organic* up 12.5% and up 7.8%, respectively GAAP operating margin of 11.1%, compared to 11.0% in prior year period Non-GAAP operating margin* of 19.7%, compared […]

Smackover Lithium Receives Key Final Integration Approval from the Arkansas Oil and Gas Commission for South West Arkansas Project

(TSX-V:SLI),(Boerse Frankfurt – Freiverkehr:S5L),(NYSE MKT:SLI), LEWISVILLE, Ark., Oct. 30, 2025 (GLOBE NEWSWIRE) — Smackover Lithium, a 55:45 owned Joint Venture (“JV”) between Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI) and Equinor (“Equinor”), is pleased to announce unanimous approval from the Arkansas Oil and Gas Commission (“AOGC”) for its Integration Application

Hub Group Reports Third Quarter 2025 Results

(NASDAQ:HUBG), Highlights: GAAP diluted earnings per share (EPS) of $0.47 for the third quarter Third quarter revenue of $934 million Non-GAAP adjusted EPS of $0.49, which excludes adjusted items in the quarter Operating income of $39 million or 4.2% of revenue, adjusted operating income (non-GAAP) of $41 million or 4.4% of revenue Closed on the

Fossil Group, Inc. Announces Date for Third Quarter 2025 Earnings Release and Conference Call

Fossil Group, Inc. Announces Date for Third Quarter 2025 Earnings Release and Conference Call GlobeNewswire October 30, 2025 RICHARDSON, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) — Fossil Group, Inc. (NASDAQ: FOSL) announced today that it will report third quarter 2025 financial results after market close on Thursday, November 13, 2025, followed by a conference call

Hubbell Incorporated Prices Offering of Senior Notes Due 2035

Hubbell Incorporated Prices Offering of Senior Notes Due 2035 GlobeNewswire October 30, 2025 Shelton, CT, Oct. 30, 2025 (GLOBE NEWSWIRE) — Hubbell Incorporated (NYSE: HUBB) (“Hubbell” or the “Company”) today announced that it has successfully priced an offering of $400 million aggregate principal amount of 4.80% senior notes maturing in 2035. The offering is expected

AppFolio, Inc. Announces Third Quarter 2025 Financial Results

AppFolio, Inc. Announces Third Quarter 2025 Financial Results Strong unit and revenue growth driven by customer acquisition, expansion, and Realm-X adoption through premium tiers and value added services GlobeNewswire October 30, 2025 SANTA BARBARA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — AppFolio, Inc. (NASDAQ: APPF) (“AppFolio” or the “Company”), a technology leader powering the future

Exponent Reports Third Quarter of Fiscal Year 2025 Financial Results

Exponent Reports Third Quarter of Fiscal Year 2025 Financial Results GlobeNewswire October 30, 2025 MENLO PARK, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter of fiscal year 2025 ended October 3, 2025. “Exponent delivered a strong third quarter, achieving double digit net revenue growth

Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025

(NasdaqGM:RLAY), CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report third quarter 2025 financial results and corporate highlights after the U.S. financial markets close on Thursday, November 6, 2025. About Relay Therapeutics

Legence Announces Extension and Repricing of Term Loan along with Increase and Extension of Revolving Credit Facility

(NASDAQ:LGN), SAN JOSE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today announced the amendment of its $798 million Term Loan Credit Facility, extending the maturity date by three years to December 16, 2031 and reducing the applicable interest rate to Secured Overnight Financing Rate (“SOFR”) plus 2.25%,

Exponent Declares Regular Quarterly Dividend for Q4 2025 and Increases Stock Repurchase Authorization by $100 Million

Exponent Declares Regular Quarterly Dividend for Q4 2025 and Increases Stock Repurchase Authorization by $100 Million GlobeNewswire October 30, 2025 MENLO PARK, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be

Scroll to Top